View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Paycom Software Inc: 1 director

A director at Paycom Software Inc sold 3,900 shares at 143.304USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

 PRESS RELEASE

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, July 05, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on July 3, 2024, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, options to purchase 484,000 shares of the Company's common stock in connection with their employment. T...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 3, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 2, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: July 1, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 28, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Eliem Therapeutics Announces its Addition to the Russell 2000® and Rus...

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes SEATTLE and CAMBRIDGE, United Kingdom, June 28, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ELYM), announced today that the Company will be included in the Russell 2000® Index and the broad-market Russell 3000® Index, as part of the annual reconstitution of the Russell stock indexes, effective today. “We are pleased to have earned inclusion in the Russell indexes, among the most widely used benchmarks for small-cap stocks," said Dr. Aoife Brennan, CEO of Eliem Therapeutics. “This is an important milestone f...

 PRESS RELEASE

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet M...

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement Eliem to focus on advancing TNT119, an anti-CD19 antibody designed to treat a broad range of autoimmune diseases, including systemic lupus erythematosus, immune thrombocytopenia and membranous nephropathy Post-close cash and cash equivalents of $220 million expected to fund operations into 2027, to enable the potential attainment of key clinical and development milestones for TNT119 Announces the appointments of Dr. Aoife Brennan as President, Chief Executive Office...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 26, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Taysha Gene Therapies Announces Pricing of Public Offering of Common S...

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants DALLAS, June 26, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced the pricing of an underwritten public offering of 14,361,113 shares of its common stock at a price to the public of $2.25 per share and, in lieu of common stock to certain investors, pre-funded warrants to purchase 18...

 PRESS RELEASE

Taysha Gene Therapies Announces Proposed Public Offering of Common Sto...

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants DALLAS, June 25, 2024 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that it has commenced an underwritten public offering of up to $75 million of shares of its common stock and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase shares of its co...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 24, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 22, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 21, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights.com Daily Ratings Report: June 20, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

Taysha Gene Therapies Announces Positive Clinical Data Across Adult an...

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome Durable improvements across consistent clinical domains in both adult and pediatric patients, including motor skills, communication/socialization, autonomic function, seizures, and an encouraging safety profile seen across adult (up to 52 weeks) and pediatric (up to 22 weeks) patients with different genetic mutation severity Longer-term data from both adult patients showed sustained and new improvements acros...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Report: June 15, 2024

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

OXY OCCIDENTAL PETROLEUM CORPORATION
Z ZILLOW GROUP INC. CLASS C
WSR WHITESTONE REIT
TTSH TILE SHOP HOLDINGS INC.
SHEN SHENANDOAH TELECOMMUNICATIONS COMPANY
PEB PEBBLEBROOK HOTEL TRUST
PBF PBF ENERGY INC. CLASS A
NFBK NORTHFIELD BANCORP INC.
GLP GLOBAL PARTNERS LP
CTRN CITI TRENDS INC.
BNED BARNES & NOBLE EDUCATION INC.
ACRS ACLARIS THERAPEUTICS INC.
MXCT MAXCYTE INC
HTLD HEARTLAND EXPRESS INC.
NSA NATIONAL STORAGE AFFILIATES TRUST
OPOF OLD POINT FINANCIAL CORP.
ZOM ZOMEDICA PHARMACEUTICALS CORP
HWKN HAWKINS INC.
GBDC GOLUB CAPITAL BDC INC.
UBFO UNITED SECURITY BANCSHARE
AFB ALLIANCEBERNSTEIN NATIONAL MUNICIPAL INCOME FUND
BOMN BOSTON OMAHA
ICCH ICC HOLDINGS
CLF CLIFFS NATURAL RESOURCES INC.
FF FIRST MINING GOLD
VPLM VOIP PAL.COM INC.
ANIX ANIXA BIOSCIENCES
RRBI RED RIVER BANCSHARES
MCFT MASTERCRAFT BOAT HOLDINGS
RZLT REZOLUTE
HQL INC.
KRON TEKLA LIFE SCIENCES INVESTORS
TLS KRONOS BIO
CSU TELOS
FTHM CAPITAL SENIOR LIVING
NUVB FATHOM HOLDINGS
CTOS NUVATION BIO INC (A)
TMCI CUSTOM TRUCK ONE SOURCE
FRTX INC.
BHRB TREACE MED CONCEPTS INC
CCFN FRESH TRACKS THERAPEUTICS
VFC INC.
UHG BURKE & HERBERT BANK & TR/VA
BYON CCFNB BANCORP INC
FTREV VF CORPORATION
OPAD UNITED HOMES GROUP INC
STCN BEYON 3D LTD
AEI FORTREA HOLDINGS INC.
GNT OFFERPAD SOLUTIONS INC
CATX STEEL CONNECT INC
PYYX ALSET INC.
PRSO GABELLI NATURAL RESOURCES
GRUSF GOLD AND INCOME TRUST
NUZE PERSPECTIVE THERAPEUTICS
MCI INC.
PYXUS INTERNATIONAL INC
PERASO INC.
GROWN ROGUE INTERNATIONAL INC.
NUZEE INC.
MASSMUTUAL CORPORATE INVESTORS
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch